Zura Bio Limited fell 69.7% on Monday, November 9, 2026, on 63,874,437 shares, 17 times its average daily volume. Headlines around the move:
Zura Bio Limited (ZURA:NASDAQ) closed at $1.24 on November 9, 2026, down 69.68% on the day. The stock trades 83.3% below its 52-week high of $7.44 and 32.8% above its 52-week low of $0.934. Over the past year, it lost 71.9%. Zura Bio Limited is part of the Health Care sector.
In 252 trading sessions since November 7, 2025, ZURA closed higher on 130 days (52%). Its best day was January 21, 2026 (+26.15%) and its worst was November 9, 2026 (-69.68%). The stock moved 10% or more in a single session 14 times.
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.
Find more stocks like ZURA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.